Low-dose Methotrexate: Determinants for Adverse Events

What are the relative risks of adverse events in patients exposed to low-dose methotrexate vs. placebo, and what factors might predispose patients to these events?
The British Journal of Dermatology

http://ift.tt/2ChnvQe